Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer
Fernanda Musa, Bhavana Pothuri, Stephanie V. Blank, Huichung T. Ling, James L. Speyer, John Curtin, Leslie Boyd, Xiaochun Li, Judith D. Goldberg, Franco Muggia, Amy Tiersten
Research output: Contribution to journal › Article › peer-review
33Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer'. Together they form a unique fingerprint.